1. Home
  2. IMRN vs BLBX Comparison

IMRN vs BLBX Comparison

Compare IMRN & BLBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • BLBX
  • Stock Information
  • Founded
  • IMRN 1994
  • BLBX 2014
  • Country
  • IMRN Australia
  • BLBX United States
  • Employees
  • IMRN N/A
  • BLBX N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • BLBX EDP Services
  • Sector
  • IMRN Health Care
  • BLBX Technology
  • Exchange
  • IMRN Nasdaq
  • BLBX Nasdaq
  • Market Cap
  • IMRN 10.1M
  • BLBX 10.6M
  • IPO Year
  • IMRN N/A
  • BLBX N/A
  • Fundamental
  • Price
  • IMRN $1.75
  • BLBX $3.49
  • Analyst Decision
  • IMRN Strong Buy
  • BLBX
  • Analyst Count
  • IMRN 1
  • BLBX 0
  • Target Price
  • IMRN $5.00
  • BLBX N/A
  • AVG Volume (30 Days)
  • IMRN 13.7K
  • BLBX 240.1K
  • Earning Date
  • IMRN 04-15-2025
  • BLBX 05-14-2025
  • Dividend Yield
  • IMRN N/A
  • BLBX N/A
  • EPS Growth
  • IMRN N/A
  • BLBX N/A
  • EPS
  • IMRN N/A
  • BLBX N/A
  • Revenue
  • IMRN $4,048,286.00
  • BLBX $2,566,946.00
  • Revenue This Year
  • IMRN N/A
  • BLBX N/A
  • Revenue Next Year
  • IMRN N/A
  • BLBX N/A
  • P/E Ratio
  • IMRN N/A
  • BLBX N/A
  • Revenue Growth
  • IMRN 82.90
  • BLBX N/A
  • 52 Week Low
  • IMRN $1.70
  • BLBX $1.51
  • 52 Week High
  • IMRN $3.09
  • BLBX $6.00
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 41.07
  • BLBX 50.52
  • Support Level
  • IMRN $1.73
  • BLBX $3.07
  • Resistance Level
  • IMRN $2.09
  • BLBX $3.84
  • Average True Range (ATR)
  • IMRN 0.14
  • BLBX 0.45
  • MACD
  • IMRN 0.00
  • BLBX -0.02
  • Stochastic Oscillator
  • IMRN 10.26
  • BLBX 44.14

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About BLBX Blackboxstocks Inc.

Blackboxstocks Inc is a financial technology and social media hybrid platform offering real-time proprietary analytics and news for stock and options traders of all levels. Its web-based software (the Blackbox System) employs predictive technology enhanced by artificial intelligence to find volatility and unusual market activity that may result in a rapid change in the price of a stock or option. It provides users with a fully interactive social media platform that is integrated into its dashboard, enabling users to exchange information and ideas quickly and efficiently through a common network. The company introduced a live audio/video feature that allows members to broadcast on their channels to share trading strategies and market insight within the Blackbox community.

Share on Social Networks: